CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
SSP treatmentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02663063
NCT02663063N/ACompleted
CompareCT.gov

The Application of Evidence-Based Chinese Complementary and Alternative Medicine (CAM) in Hospice Palliative Care in Taiwan-The Second and Third Year Project.

Taipei Veterans General Hospital, Taiwan·interventional·Posted Jan 26, 2016·Updated Feb 22, 2023

In Brief

A clinical study evaluating SSP treatment for Cancer. Completed, enrolled 60 participants across 1 site.

Detailed Summary

The study aims to explore the effects of silver spike point (SSP) treatment on common symptoms including pain, breathlessness, nausea/vomiting, dry mouth etc. of terminal cancer patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCancer
CountriesTaiwan
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJan 26, 2016
Enrollment StartDec 1, 2015
Primary CompletionSep 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 10.4 years ago

Interventions

SSP treatmentdevice

SSP treatment 5 times a week